Jump to content

Search the Community

Showing results for tags 'COVID-19'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type



Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Salutation


Country


Occupation


Organization


Website


I am joining because:

Found 18 results

  1. FAQs regarding the flu season 2021-2022. The questions and answers include information on the flu vaccine, the viral strains circulating, the flu vaccine coverage, information on seasonal flu in the context of COVID-19, as well as information for healthcare professionals. Resource available in Spanish.
  2. Educational video on thrombosis with thrombocytopenia syndrome following adenoviruses vaccines against COVID-19.
  3. The National Foundation for Infectious Diseases (NFID) convened a multidisciplinary group of experts at a virtual roundtable in January 2021 to share research, insights, and best practices for improving and harmonizing communication to the public about the evolving COVID-19 pandemic and the importance of following evidence-based public health prevention measures.
  4. Qui peut se faire vacciner aujourd’hui contre le Covid-19 ? Comment prendre rendez-vous pour cette vaccination ? Quels sont les effets secondaires des vaccins autorisés en France ? Comment la sécurité des vaccins est-elle garantie ? La campagne vaccinale contre le Covid-19 se poursuit et suscite toujours de nombreuses interrogations. Franceinfo s'efforce d’y répondre dans le cadre de son opération #OnVousRépond. Vous trouverez ici nos réponses aux questions les plus fréquentes sur les vaccins contre le Covid-19. Il est possible de compléter avec les sites des autorités sanitaires, les travaux des sociétés savantes (comme ce dossier de la Société de pathologie infectieuse de langue française) et bien entendu auprès de son médecin.
  5. Misinformation threatens the success of vaccination programs across the world. Unicef, First Draft, Yale Institute for Global Health, and PGP (The Public Good Projects) have partnered to create the Vaccine Misinformation Management Field Guide. This guide aims to help organizations to address the global infodemic through the development of strategic and well-coordinated national action plans to rapidly counter vaccine misinformation and build demand for vaccination that are informed by social listening.
  6. La pandémie de Covid-19 ayant causé plus de 100 millions de cas et plus de 2,3 millions de morts à l’échelle mondiale, la publication des résultats des études pivot des premiers candidats-vaccins contre la Covid-19 a été une source d’espoir pour la communauté internationale. De nombreux pays ont rapidement initié une campagne vaccinale contre la Covid19 ; plus de 150 millions de doses ont été administrées dans le monde au 12 février 2021 (https://ourworldindata.org/covid-vaccinations). De nombreuses questions ont été soulevées en France, à la fois par les décideurs en Santé publique, mais aussi très vite par les soignants et acteurs de terrain, en charge d’informer la population, de définir et repérer les personnes prioritaires et de mettre en place la campagne vaccinale en France. Devant cette demande forte d’éclairage simple et objectif des données disponibles, la Société de Pathologie Infectieuse de Langue Française (SPILF) a été sollicitée pour élaborer un document d’information à destination des professionnels de santé.
  7. In Episode 1 of our new podcast series, Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, talks with Stanley Plotkin, Emeritus Professor of Paediatrics at the University of Pennsylvania; who is well known internationally for his role in vaccine development. In this episode they discuss:•Professor Plotkin’s role in the development of the rubella vaccine, still used throughout the world today •His role as the Editor in Chief of the ‘Vaccines’ textbook •His role in the formation of the Coalition for Epidemic Preparedness and Innovation (CEPI) and CEPI’s current role in global COVID-19 vaccine development •What can we learn from the H1N1 pandemic in the development of a COVID-19 vaccine? •How developing a vaccine against coronaviruses is critical to the future of civilisation as economies are being destroyed by these viruses •Human challenge models and some of the ethical considerations we need to tackle if these sorts of trials are going to be undertaken to support COVID-19 vaccine development •Success can only be achieved through global collaboration in the pursuit of a COVID-19 vaccine •How the practical aspects of distributing a vaccine on this scale have never been faced before and the importance of thinking outside the box!
  8. Information about COVID-19 vaccines is quickly evolving and WHO will aim to update this Q&A on an ongoing basis, as we learn more.
  9. General Q & A for COVID-19 and related topics including: advices for adolescents and youth, breastfeeding, masks, children and masks. cleaning and disinfecting, climate, family planning, dexamethasone, food safety, hydroxychloroquine and others.
  10. Questions from healthcare workers regarding routine vaccination during pandemic.
  11. Avec TousAntiCovid, participez à la lutte contre l’épidémie en réduisant les risques de transmission.f
  12. The Brown School of Public Health and Rockefeller Foundation Release recently released a COVID-19 Testing Communications Toolkit which provides messaging, illustrations, pre-made social posts, and handouts that are easy to download and use. The COVID-19 Testing Communications Toolkit is a free, public resource for anyone looking to communicate the importance of COVID-19 testing to communities across America. The evidence-based tutorials, handouts, and image library will help communicators translate public health goals into motivating, clear messages that educate Americans about why, when, and where to get tested — even if they feel healthy. These materials are available in multiple languages. Plus, add style to message with their custom-designed asset library. The images, animations, handouts, and templates are all completely free and available for unrestricted public use.
  13. If you have been wondering when you would receive your vaccine, why you should get vaccinated and are concerned about what your are hearing about side effects, this episode of Science with 5 with WHO’s Chief Scientist Dr Soumya Swaminathan is for you.
  14. Ready-made materials you can use to inform your healthcare teams and other staff. Medical centers, clinics, pharmacies, and clinicians can use or adapt these ready-made materials to build confidence about COVID-19 vaccination among your healthcare teams and other staff. Step 1: Educate healthcare teams and other staff. Step 2: Give them the tools they can use to educate patients and answer their questions about the vaccines.
  15. In recognition of the critical importance of COVID-19 vaccines and the need to understand their safety, the CONSIDER (COvid-19 vacciNe Safety questIons anD hEalthcare pRoviders) working group (WG) was created in September 2020. The CONSIDER WG aims to provide clear, comprehensive answers to questions pertaining to COVID-19 vaccine safety prior to, and during the vaccines roll out to 1) facilitate scientific discussion between stakeholders, including front line health workers with potential vaccine recipients and 2) increase comprehension and transparency of information to facilitate acceptance and uptake.
  16. In episode 4 of our COVID-19 Road to a vaccine series, we spoke with Professor Kanta Subbarao. Professor Subbarao has been the Director of the World Health Organisation Collaborating Centre for Reference and Research on Influenza since 2016, based at The Doherty Institute at the University of Melbourne, Australia. In episode 5 of our COVID-19 Road to a vaccine series, we spoke with Professor Terry Nolan, who is a Redmond Barry Distinguished Professor at the Doherty Institute for Infection and Immunity. He heads up VIRGO, the vaccine and immunisation research group, a collaboration between Murdoch Children's Research Institute and the University of Melbourne. VIRGO has the largest and longest standing child and adolescent vaccine population research and clinical trials program in Australia.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines